This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
ORIGINAL RESEARCH PAPER
Gidekel, S. et al. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4, 361–370 (2003)
Rights and permissions
About this article
Cite this article
Greenwood, E. Determining fate. Nat Rev Cancer 4, 6 (2004). https://doi.org/10.1038/nrc1262
Issue date:
DOI: https://doi.org/10.1038/nrc1262